Yannick LeMeur

7PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMedical virologyMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 01, 2023
Evaluation of the efficacy of HEMO<sub>2</sub>life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial.

Yannick Le Meur, Emmanuel Nowak, Benoit Barrou

|Jan 06, 2022
Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial.

Hannah Kaminski, Nassim Kamar, Olivier Thaunat

|Dec 24, 2021
HEMO<sub>2</sub> life® improves renal function independent of cold ischemia time in kidney recipients: A comparison with a large multicenter prospective cohort study.

Yannick Le Meur, Eric Delpy, Felix Renard

|Oct 23, 2021
Selection of <i>Pneumocystis jirovecii</i> Inosine 5'-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid.

Claire V Hoffmann, Gilles Nevez, Marie-Christine Moal

|Dec 03, 2020
Among CMV-positive renal transplant patients receiving non-T-cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients.

Hugoline Boulay, Emmanuel Oger, Diego Cantarovich

|Dec 01, 2020
Is COVID-19 infection more severe in kidney transplant recipients?

Sophie Caillard, Nathalie Chavarot, Hélène Francois

Pageof 2

Frequent Collaborators

2 joint publications

Nassim Kamar

2 joint publications

Olivier Thaunat

2 joint publications

Dany Anglicheau

2 joint publications

Antoine Durrbach